NFXBio: TechBio Platforms Developing a Universal Vaccine & Beating Treatment-Resistant Cancer
The NFX Podcast - A podcast by NFX
In this episode, Nick Goldner and Jacob Glanville share their founder journeys and discuss platform technologies in biotech. They delve into the business models of Resistance Bio and Sentivax, strategies for infectious diseases, and the challenges of scientific entrepreneurship. The conversation shifts to fundraising experiences and understanding investor feedback, concluding with visions for the future of biotech.
